View source for 18556461. GLUCAGON LIKE PEPTIDE COMPOUNDS simplified abstract (Novartis AG)

=GLUCAGON LIKE PEPTIDE COMPOUNDS=


==Organization Name==

[[:Category:Novartis AG|Novartis AG]]


[[Category:Novartis AG]]

==Inventor(s)==

[[:Category:Valerie Beaulieu of North Reading MA (US)|Valerie Beaulieu of North Reading MA (US)]][[Category:Valerie Beaulieu of North Reading MA (US)]]

[[:Category:Keith Galyan of Lake Villa IL (US)|Keith Galyan of Lake Villa IL (US)]][[Category:Keith Galyan of Lake Villa IL (US)]]

[[:Category:Jinhai Gao of Belmont MA (US)|Jinhai Gao of Belmont MA (US)]][[Category:Jinhai Gao of Belmont MA (US)]]

[[:Category:Carol Ginsburg-moraff of Cambridge MA (US)|Carol Ginsburg-moraff of Cambridge MA (US)]][[Category:Carol Ginsburg-moraff of Cambridge MA (US)]]

[[:Category:Pankaj Jain of Belmont MA (US)|Pankaj Jain of Belmont MA (US)]][[Category:Pankaj Jain of Belmont MA (US)]]

[[:Category:Jovita Marcinkeviciene of Lexington MA (US)|Jovita Marcinkeviciene of Lexington MA (US)]][[Category:Jovita Marcinkeviciene of Lexington MA (US)]]

[[:Category:Walter Michael of Watertown MA (US)|Walter Michael of Watertown MA (US)]][[Category:Walter Michael of Watertown MA (US)]]

[[:Category:Muneto Mogi of Waltham MA (US)|Muneto Mogi of Waltham MA (US)]][[Category:Muneto Mogi of Waltham MA (US)]]

[[:Category:Martin Marro of Newton MA (US)|Martin Marro of Newton MA (US)]][[Category:Martin Marro of Newton MA (US)]]

[[:Category:Sejal Patel of Lexington MA (US)|Sejal Patel of Lexington MA (US)]][[Category:Sejal Patel of Lexington MA (US)]]

[[:Category:Scott Plummer of Somerville MA (US)|Scott Plummer of Somerville MA (US)]][[Category:Scott Plummer of Somerville MA (US)]]

[[:Category:Alok Singh of Sudbury MA (US)|Alok Singh of Sudbury MA (US)]][[Category:Alok Singh of Sudbury MA (US)]]

[[:Category:Aimee Usera of Winchester MA (US)|Aimee Usera of Winchester MA (US)]][[Category:Aimee Usera of Winchester MA (US)]]

==GLUCAGON LIKE PEPTIDE COMPOUNDS - A simplified explanation of the abstract==


This abstract first appeared for US patent application 18556461 titled 'GLUCAGON LIKE PEPTIDE COMPOUNDS

'''Simplified Explanation:'''
The patent application describes novel compounds that combine a GLP-1 compound with a fatty acid or its derivative.

* These compounds are manufactured and used for their potential benefits in various applications.
* The innovation lies in the unique combination of GLP-1 and fatty acids, offering new possibilities in the field.
* The compounds may have implications in the treatment of certain conditions or diseases.
* By addressing specific problems related to GLP-1 and fatty acids, these compounds offer a novel approach to therapy.
* The benefits of these compounds may include improved efficacy and reduced side effects compared to existing treatments.

'''Potential Applications:'''
The technology could be applied in the pharmaceutical industry for the development of new therapies targeting metabolic disorders or other conditions.

'''Problems Solved:'''
The technology addresses challenges related to the effectiveness and side effects of existing GLP-1-based treatments.

'''Benefits:'''
The technology offers the potential for enhanced therapeutic outcomes and improved patient experiences.

'''Commercial Applications:'''
The technology could have commercial applications in the development of novel pharmaceutical products for metabolic disorders, potentially impacting the market for related treatments.

'''Questions about GLP-1 and Fatty Acid Compounds:'''
1. What are the potential therapeutic applications of combining GLP-1 compounds with fatty acids?
2. How do these novel compounds compare to existing treatments in terms of efficacy and side effects?


==Original Abstract Submitted==

Provided herein are novel compounds comprising a GLP-1 compound and a fatty acid or fatty acid derivative, the manufacture of said novel compounds and the use thereof.



[[Category:C07K14/605]]
[[Category:A61K38/00]]
[[Category:A61K47/54]]
[[Category:A61P3/04]]
[[Category:CPC_C07K14/605]]